BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 18018575)

  • 21. Multiple endocrine neoplasia type 2A in a kindred with C634Y mutation.
    Jackson MB; Guttenberg M; Hedrick H; Moshang T
    Pediatrics; 2005 Sep; 116(3):e468-71. PubMed ID: 16099853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rare thyroid tumors: spindle-cell epithelial tumor and thyroid carcinoma with thymus-like differentiation].
    Abrosimov AIu; Dvinskikh NIu; Rotin DL
    Arkh Patol; 2007; 69(6):34-7. PubMed ID: 18290379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistent familial nonmultiple endocrine neoplasia medullary thyroid carcinoma and papillary thyroid carcinoma associated with RET polymorphism.
    Gul K; Ozdemir D; Ugras S; Inancli SS; Ersoy R; Cakir B
    Am J Med Sci; 2010 Jul; 340(1):60-3. PubMed ID: 20463576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medullary thyroid carcinoma.
    Hoff AO; Hoff PM
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):475-88; viii. PubMed ID: 17548035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic molecular biology in solid tumors--thyroid gland].
    Faksvåg Haugen DR; Varhaug JE; Akslen LA; Lillehaug JR
    Tidsskr Nor Laegeforen; 1998 May; 118(14):2199-203. PubMed ID: 9656818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of medullary carcinoma of the thyroid during pregnancy in a patient with an intron substitution.
    Walshe P; Seaberg RM; Yehuda M; Freeman J
    J Otolaryngol Head Neck Surg; 2008 Apr; 37(2):E39-41. PubMed ID: 19137655
    [No Abstract]   [Full Text] [Related]  

  • 27. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medullary thyroid cancer - the present state of art].
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple endocrine neoplasia type IIa (MEN2A)].
    Hashizume K; Suzuki S; Shigematsu S; Takeda T
    Nihon Rinsho; 2006 Sep; Suppl 3():337-42. PubMed ID: 17022559
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multimodal imaging in medullary thyroid carcinomas].
    Müssig K; Bares R; Horger M
    Rofo; 2010 Nov; 182(11):925-8. PubMed ID: 21031322
    [No Abstract]   [Full Text] [Related]  

  • 31. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple endocrine neoplasia type 2a and 2b].
    Vestergaard P
    Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma].
    Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J
    Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular advances in medullary thyroid cancer diagnostics.
    Hubner RA; Houlston RS
    Clin Chim Acta; 2006 Aug; 370(1-2):2-8. PubMed ID: 16519882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.
    Volante M; Papotti M; Roth J; Saremaslani P; Speel EJ; Lloyd RV; Carney JA; Heitz PU; Bussolati G; Komminoth P
    Am J Pathol; 1999 Nov; 155(5):1499-509. PubMed ID: 10550306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological investigation of thyroid cancer].
    Douik H; Ghanem A; Jmal A; Harzallah L; Gara S; Abdennebi M; Boussen H; Guemira F
    Tunis Med; 2006 Mar; 84(3):135-41. PubMed ID: 16755952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted therapy: a new hope for thyroid carcinomas.
    Perri F; Pezzullo L; Chiofalo MG; Lastoria S; Di Gennaro F; Scarpati GD; Caponigro F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):55-63. PubMed ID: 25465739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterotopic intrathymic thyroid tissue.
    Hwang I; Lee SK; Cho KJ; Kim KR
    Pathol Int; 2006 Oct; 56(10):629-32. PubMed ID: 16984621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.